相关实验视频

Updated: Jun 22, 2025

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

少是多:探索新辅助免疫疗法作为头部和部状细胞癌治疗中的降级策略

Lei-Ming Cao¹, Nian-Nian Zhong¹, Yang Chen¹

¹State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Somatology, School & Hospital of Stomatology, Wuhan University, Wuhan, 430079, China.

|July 4, 2024

概括

新辅助免疫疗法 (NAIT) 对头角状细胞癌 (HNSCC) 治疗具有前景,有可能改善结果并使缓解升级策略成为可能. 需要进一步的研究来优化NAIT,以提高HNSCC患者的生活质量.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
癌症研究癌症研究

背景情况:

头部和部状细胞癌 (HNSCC) 是一个重大的全球卫生挑战,死亡率高.
目前的多学科治疗改善了生存率,但导致严重的毒性和功能性损害.
新辅助化疗 (NACT) 有好处,但没有显著改善HNSCC的整体存活率.

研究的目的:

审查新辅助免疫疗法 (NAIT) 策略,专注于针对HNSCC的免疫检查点抑制剂 (ICI).
探索NAIT内部对HNSCC治疗的潜在降级策略.
确定挑战,并为改善HNSCC患者生活质量的未来研究提供信息.

主要方法:

对HNSCC中新辅助免疫检查点抑制剂 (ICI) 的现有文献的审查.
从NAIT的临床试验中分析放射和病理反应数据.
在HNSCC.NAIT中探索降级概念和相关挑战.

主要成果:

新辅助免疫疗法 (NAIT) 在HNSCC.中显示出有前途的放射性和病理反应.
在临床试验中,NAIT显示出令人鼓舞的疗效,这表明治疗降级的潜力.
免疫检查点抑制剂 (ICI) 是当前NAIT策略的关键组成部分.

结论:

NAIT为改善HNSCC治疗疗效和潜在降低治疗升级提供了一个有希望的途径.
对NAIT和降级策略的进一步研究对于提高患者生活质量至关重要.
解决NAIT降级方面的挑战对于HNSCC的未来临床应用至关重要.

关键词:

头部和部状细胞癌瘤免疫检查点抑制剂免疫检查点抑制剂新辅助免疫疗法新辅助免疫疗法生活质量生活的质量.处理缓和升级的治疗.

更多相关视频

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...